The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]

  Cancer survivors, cancer patients, friends, family and caregivers are invited to attend Living Beyond Cancer A-Z, a free symposium on Jan. 21, put on by the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. It will feature a full day of learning, empowerment and discovery and will take place […]